Vertex Pharmaceuticals logo

Strategy and Operations Associate Director, Cell & Genetic Therapy Research

Vertex Pharmaceuticals
June 25, 2026
Remote friendly (Boston, MA)
United States
Operations
Strategy & Operations Associate Director

Responsibilities:
- Translate enterprise and disease area strategies into CGT Research-specific execution plans, including capacity requirements, shared platform constraints, sequencing decisions, resource trade-offs, and key milestones.
- Frame strategic options/trade-offs for leadership decision-making with decision-ready analysis (execution risks, resource constraints, cross-functional dependencies).
- Conduct scenario planning and options analysis with the Head of LC Research Strategy & Operations and LC Research Site Head.
- Drive goal setting, prioritization frameworks, and execution risk management across research functions; improve operating processes, coordination, and efficiency.
- Partner with Finance on OpEx planning, headcount management, and resource allocation aligned to strategic priorities.
- Create executive communications (presentations, briefing materials, decision documents) and synthesize complex scientific/operational/strategic information for diverse audiences.
- Coordinate cross-functional teams (PPM, DSTs, Finance/HR/Operations and enabling functions) to ensure alignment on priorities, constraints, interdependencies, decisions, and action plans.
- Support RS&O Head as liaison between LC Research and BD/External Innovation by translating external opportunities into research implications.

Qualifications:
- PhD in biology (or related); 8+ years’ experience; MBA/Consulting background preferred.
- Experience advising research leadership on strategic/operational topics.
- Cross-functional execution experience with medium- to large-scale projects.

Skills:
- Strategic thinking, analytical rigor, strong written/oral communication, leadership influence, organizational agility, collaboration, business acumen, independence/judgment.

Pay range: $155,700 - $233,500. Eligible for annual bonus and annual equity awards.